Received May 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
COVID; COVID; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 72-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Primary immunization series complete), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 28Apr2025, outcome "unknown" and all described as "COVID". Clinical course: The patient stated she received the "Pfizer shot and a lot of, like, boosters." The patient was getting ready to get the next boosters. On the morning of 28Apr2025, the patient had a sore throat, and it turned out that she had COVID. The patient also said that in the morning she went to urgent care, and she was tested. The patient said she tested positive for COVID and was prescribed nirmatrelvir; ritonavir (PAXLOVID). The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (28Apr2025) Positive. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.
Test Date: 20250428; Test Name: Covid-19 test; Test Result: Positive